Amarin Corp Plc (AMRN)

[Biobillionair]

G-"efficacy should be proved also" There was a high degree of data pointing to the efficacy of Vascepa to prevent CVE. If a drug is ultra-safe it becomes a risk/reward medical decision that's should be left up to patients and physicians...something the pencil pushers at the FDA don't understand. Instead the FDA cancel an entire surrogate marker due to unrelated studies on different drugs not even studying the same biomarker. Very bad science.
BB